These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 36652279)

  • 1. Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.
    Gisbert JP; García MJ; Chaparro M
    J Crohns Colitis; 2023 Jun; 17(6):972-994. PubMed ID: 36652279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
    Veyrard P; Pellet G; Laharie D; Nachury M; Juillerat P; Roblin X
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1354-1355.e2. PubMed ID: 35307594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies.
    Calméjane L; Laharie D; Kirchgesner J; Uzzan M
    United European Gastroenterol J; 2023 Oct; 11(8):722-732. PubMed ID: 37475143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis.
    Wu D; Yang Z; Zhao C; Yao L
    Medicine (Baltimore); 2018 Oct; 97(41):e12657. PubMed ID: 30313056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: the practical management of acute severe ulcerative colitis.
    Seah D; De Cruz P
    Aliment Pharmacol Ther; 2016 Feb; 43(4):482-513. PubMed ID: 26725569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern practical management of acute severe colitis.
    AbdelMeguid AMA; Whitehead E; Sebastian S
    Indian J Gastroenterol; 2024 Feb; 43(1):78-92. PubMed ID: 38407787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
    García MJ; Riestra S; Amiot A; Julsgaard M; García de la Filia I; Calafat M; Aguas M; de la Peña L; Roig C; Caballol B; Casanova MJ; Farkas K; Boysen T; Bujanda L; Cuarán C; Dobru D; Fousekis F; Gargallo-Puyuelo CJ; Savarino E; Calvet X; Huguet JM; Kupcinskas L; López-Cardona J; Raine T; van Oostrom J; Gisbert JP; Chaparro M
    Aliment Pharmacol Ther; 2024 May; 59(10):1248-1259. PubMed ID: 38445785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
    Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential Use of High-Dose Tofacitinib After Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis.
    Gilmore R; Hilley P; Srinivasan A; Choy M; De Cruz P
    J Crohns Colitis; 2022 Jan; 16(1):166-168. PubMed ID: 34159363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis.
    Vitali F; Rath T; Klenske E; Vögele AL; Ganzleben I; Zundler S; Strobel D; Geppert C; Hartmann A; Neurath MF; Atreya R
    Therap Adv Gastroenterol; 2024; 17():17562848231218555. PubMed ID: 38164363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis.
    Chang KH; Burke JP; Coffey JC
    Int J Colorectal Dis; 2013 Mar; 28(3):287-93. PubMed ID: 23114475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center.
    Evirgen S; İliaz R; Akyüz F; Çavuş B; Göktürk S; Örmeci A; Mutluay Soyer Ö; Baran B; Pınarbaşı B; Karaca Ç; Demir K; Beşışık F; Kaymakoğlu S
    Turk J Gastroenterol; 2022 Jun; 33(6):463-469. PubMed ID: 35786613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Narula N; Marshall JK; Colombel JF; Leontiadis GI; Williams JG; Muqtadir Z; Reinisch W
    Am J Gastroenterol; 2016 Apr; 111(4):477-91. PubMed ID: 26856754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.
    Mocciaro F; Renna S; Orlando A; Rizzuto G; Sinagra E; Orlando E; Cottone M
    J Crohns Colitis; 2012 Jul; 6(6):681-6. PubMed ID: 22398101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study.
    Ko Y; Paramsothy S; Yau Y; Leong RW
    Aliment Pharmacol Ther; 2021 Aug; 54(3):292-301. PubMed ID: 34151447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.
    Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Vuitton L; Moreau J; Amiot A; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Fumery M; Carbonnel F; Bommelaer G; Coffin B; Roblin X; van Assche G; Esteve M; Farkkila M; Gisbert JP; Marteau P; Nahon S; de Vos M; Lambert J; Mary JY; Louis E;
    Gut; 2018 Feb; 67(2):237-243. PubMed ID: 28053054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Ordás I; Domènech E; Mañosa M; García-Sánchez V; Iglesias-Flores E; Peñalva M; Cañas-Ventura A; Merino O; Fernández-Bañares F; Gomollón F; Vera M; Gutiérrez A; Garcia-Planella E; Chaparro M; Aguas M; Gento E; Muñoz F; Aguirresarobe M; Muñoz C; Fernández L; Calvet X; Jiménez CE; Montoro MA; Mir A; De Castro ML; García-Sepulcre MF; Bermejo F; Panés J; Esteve M
    Am J Gastroenterol; 2017 Nov; 112(11):1709-1718. PubMed ID: 28675163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
    Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M;
    Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.